Camarda Financial Advisors’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-6,470
Closed -$2.39M 119
2025
Q3
$2.39M Buy
6,470
+691
+12% +$267K 0.88% 37
2025
Q2
$2.29M Buy
5,779
+1
+0% +$374 0.9% 34
2025
Q1
$2.15M Sell
5,778
-7
-0.1% -$2.66K 0.97% 33
2024
Q4
$2.08M Buy
+5,785
New +$2.14M 0.78% 41
2017
Q1
Sell
-12
Closed -$1K 247
2016
Q4
$1K Buy
+12
New +$1.38K ﹤0.01% 248
2014
Q3
Sell
-193
Closed -$16K 247
2014
Q2
$16K Hold
193
0.01% 168
2014
Q1
$16K Buy
+193
New +$15.3K 0.01% 145

Other funds holding SYK

Camarda Financial Advisors's SYK Position: Q4 2025 in Review

Camarda Financial Advisors sold out of Stryker (SYK) in Q4 2025, closing a stake of 6,470 shares — an estimated $2.39M sold.

Camarda Financial Advisors first reported a position in SYK in Q1 2014 and held it in 7 quarters. The position peaked at $2.39M in Q3 2025. 2,328 funds tracked by Wall St. Rank hold SYK as of Q4 2025.

  • Camarda Financial Advisors reported no remaining Stryker position as of Q4 2025 after selling out during the quarter.
  • Camarda Financial Advisors sold 6,470 Stryker shares in Q4 2025, an estimated $2.39M.
  • Camarda Financial Advisors first reported a position in Stryker in Q1 2014 and held it in 7 quarters.
  • Camarda Financial Advisors's Stryker position peaked at $2.39M in Q3 2025.
  • 2,328 funds tracked by Wall St. Rank held Stryker as of Q4 2025.

Based on Camarda Financial Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.